Best FDA-Approved GLP-1 Providers in 2026
By Weight Loss Provider Guide Editorial Team · Last verified: May 11, 2026
Affiliate disclosure: We may earn a commission when you visit a provider through our links. This does not affect our rankings, recommendations, or editorial independence. Not medical advice.

The best FDA-approved GLP-1 provider for most people in 2026 is Ro. It carries the broadest list of brand-name GLP-1 medications — Wegovy pill, Wegovy pen, Zepbound, the new Zepbound KwikPen, and Foundayo — at the same prices as LillyDirect, NovoCare, and TrumpRx, and it publicly advertises a dedicated insurance concierge that helps file prior-authorization paperwork. Get started for $39 the first month, then as low as $74/month with an annual plan paid upfront. Medication is billed separately. Prescription not guaranteed.
If you want to pick your own doctor and see every brand-name option side-by-side, Sesame Care is the better fit. If you'd rather skip the subscription entirely, Amazon One Medical, NovoCare Pharmacy, and LillyDirect ship the same FDA-approved medication with no membership fee.
One thing most "best of" lists won't tell you upfront: a telehealth provider can't be "FDA-approved." Only medications are FDA-approved. What you're actually shopping for is a provider that helps you access an FDA-approved drug through a licensed clinician — and a lot of the loudest programs out there mostly push compounded GLP-1s, which are a different product category entirely. We separate the two below.
Best fit if you want FDA-approved options plus help with insurance and prior authorization. Medication billed separately. Prescription not guaranteed.
What are the best FDA-approved GLP-1 providers right now?
Quick answer
| Your situation | Best first click | Why |
|---|---|---|
| I have commercial insurance — help me get it covered | Ro | Free GLP-1 Coverage Checker; insurance concierge helps file prior authorization |
| I want to pick my own doctor and see the broadest brand menu | Sesame Care | Wegovy pill, Wegovy pen, Zepbound (vial, KwikPen, pen), Foundayo, Saxenda, plus diabetes brands when clinically appropriate |
| I want transparent pricing with a familiar retailer | Amazon One Medical | Wegovy and Foundayo oral options from $149/month; injectables from $299/month; ships to all 50 states; no One Medical membership required to start |
| I want the lowest platform fee, cash-pay | GoodRx Care Direct | $39/month care fee; Foundayo and Wegovy pill from $149/month |
| I don't want any subscription at all | Walgreens Weight Management | $49/visit, no membership; FDA-approved meds start at $149/month |
| I want coaching and lifestyle support | WeightWatchers Clinic (Med+) | Insurance coordination + behavior-change tools; $25 first month with 12-month plan, renews at $74/month |
| I'm female-coded and want a familiar brand | Hers | Full Wegovy menu via Novo Nordisk; Zepbound/Foundayo prescriptions can be sent to LillyDirect Pharmacy |
| I'm male-coded and want a familiar brand | Hims | Full Wegovy menu via Novo Nordisk; Zepbound/Foundayo prescriptions can be sent to LillyDirect Pharmacy |
| I already have a prescriber — just want the cheapest | NovoCare Pharmacy (Wegovy) or LillyDirect (Zepbound, Foundayo) | Direct from the maker; no membership fee |
| I'm on Medicare Part D or MA-PD | Wait for the Medicare GLP-1 Bridge (July 1, 2026) | $50 fixed cost-sharing for Foundayo, Wegovy tablets, Wegovy injection, and Zepbound KwikPen — if you qualify |
| I'm open to compounded for a lower price | This isn't the right page | Different category, different tradeoffs — see Best GLP-1 Online Programs |
Best if your top concern is insurance, prior authorization, or choosing the right medication.
“FDA-approved” — a quick word on language
Quick answer
Why does this matter? Because a lot of online programs lead with language like “FDA-registered pharmacy” or “licensed in 50 states,” and then quietly ship you a compounded GLP-1 — a custom-compounded product made by a compounding pharmacy. Compounded semaglutide and tirzepatide are not FDA-approved as finished drugs. The FDA has issued warning letters about unapproved GLP-1 products and the specific risks of dosing errors, salt-form substitutions, and contamination tied to some compounded products.
If you're open to compounded options
The FDA-approved GLP-1 weight-loss medications you can actually get in 2026
Quick answer
| Medication | Active ingredient | Maker | Format | Trial weight loss | Approval status |
|---|---|---|---|---|---|
| Wegovy injection | Semaglutide | Novo Nordisk | Weekly pen (0.25–2.4 mg, plus 7.2 mg HD added March 2026) | ~15% at 2.4 mg (STEP-1); ~19% at 7.2 mg HD | FDA-approved for chronic weight management; also approved to reduce risk of heart attack and stroke in eligible adults with established CVD |
| Wegovy pill | Oral semaglutide | Novo Nordisk | Daily tablet (1.5, 4, 9, 25 mg) | ~14% at 25 mg (OASIS) | FDA-approved December 2025 — first FDA-approved GLP-1 weight-loss pill |
| Wegovy HD 7.2 mg | Semaglutide | Novo Nordisk | Weekly injection at higher dose | ~19% in clinical trial | FDA-approved March 2026 under the Commissioner's National Priority Voucher pilot |
| Zepbound (pen / KwikPen) | Tirzepatide (dual GIP/GLP-1) | Eli Lilly | Weekly injection (2.5–15 mg) | ~22.5% at 15 mg (SURMOUNT-1) | FDA-approved for chronic weight management; also approved for moderate-to-severe obstructive sleep apnea |
| Zepbound (single-dose vial) | Tirzepatide | Eli Lilly | Weekly injection from a vial via LillyDirect | Same as pen | Same FDA approval; sold as a cash-pay format |
| Foundayo | Orforglipron | Eli Lilly | Daily pill (0.8–17.2 mg) | ~12.4% at 17.2 mg (ATTAIN-1) | FDA-approved April 1, 2026 — the only GLP-1 pill that can be taken any time of day, with or without food or water |
| Saxenda / generic liraglutide | Liraglutide | Novo Nordisk / Teva (generic) | Daily injection | ~5–10% | FDA-approved for chronic weight management; first generic GLP-1 for weight loss launched by Teva August 2025 |
Ozempic and Mounjaro are not FDA-approved for weight loss. Ozempic is the diabetes brand of semaglutide. Mounjaro is the diabetes brand of tirzepatide. A clinician can prescribe either off-label for weight management when clinically appropriate — but if you don't have type 2 diabetes, the FDA-approved-for-weight-loss option is Wegovy (semaglutide) or Zepbound (tirzepatide).
Wegovy pill is not the same as compounded oral semaglutide. Wegovy pill is a specific FDA-approved 25 mg tablet from Novo Nordisk with a special absorption technology. Compounded "oral semaglutide" drops or troches are a different product and are not FDA-approved.
Foundayo is brand-new. It received FDA approval April 1, 2026 under the Commissioner's National Priority Voucher pilot — the fastest approval of a new molecule since 2002. Self-pay starts at $149/month for the lowest dose.
Real all-in monthly cost — every FDA-approved GLP-1 by provider (verified May 2026)
Quick answer
What we actually verified
| Access path | Platform fee | Wegovy pill | Wegovy injection | Zepbound | Foundayo | Insurance / PA support |
|---|---|---|---|---|---|---|
| Ro Body ★ | $39 first month, then $149/mo; as low as $74/mo with annual prepay | Matches NovoCare ($149–$299 by dose); Prepay & Save saves $50/mo on Wegovy pill | Matches NovoCare ($199 intro × 2 mo → $349; HD 7.2 mg $399); Prepay & Save saves $100/mo on Wegovy pen | KwikPen $299 (2.5 mg), $399 (5 mg), $449 (7.5–15 mg) with manufacturer offer; pen via insurance with concierge | $149 first month, then $199–$299/mo thereafter | Insurance concierge files prior auth; free GLP-1 Coverage Checker; FEHB only for government plans |
| Sesame Care | $99/mo monthly, or as low as $59/mo on annual plan | $149+/mo by dose | $199/mo intro × 2 mo → $349/mo (matches NovoCare) | KwikPen dose-based: $299, $398, $499, $698; vial from $299/mo via LillyDirect | $149–$349/mo by dose | Provider can assist with PA; insurance accepted for eligible meds; Costco members get 10% off services |
| Amazon One Medical / Amazon Pharmacy | No One Medical membership required to start | Wegovy pill from $149/mo | Wegovy injection from $299/mo | Zepbound from $299/mo | Foundayo from $149/mo | Transparent pharmacy pricing; ships all 50 states |
| Hims & Hers | $39 first month, renews at $149/mo | Wegovy pill 1.5/4/9/25 mg from $149/mo (Novo Nordisk access) | Wegovy injection 0.25–2.4 mg from $149/mo; 7.2 mg HD available | Affiliated providers can send prescriptions to LillyDirect Pharmacy | Affiliated providers can send prescriptions to LillyDirect Pharmacy | Self-pay focused — verify insurance handling per state at checkout |
| GoodRx Care Direct | $39/mo care fee | From $149/mo | From $199/mo | From $299/mo | From $149/mo | Not insurance — cash-pay route |
| Walgreens Weight Management | $49 per visit, no subscription | From $149/mo | From $199/mo | KwikPen dose-based: $299, $399, $449 with manufacturer offer | From $149/mo (starter); $199–$299/mo with offer at higher doses | Does not currently handle insurance or prior authorization |
| WeightWatchers Clinic (Med+) | $25 first month with 12-month plan, renews at $74/mo | Available when clinically appropriate | Available when clinically appropriate | Available when clinically appropriate | Now listed on WW Med+ | Insurance coordinator can help with coverage and PA |
| PlushCare | Visit / membership model — verify current rates | Available when clinically appropriate | Available when clinically appropriate | Available when clinically appropriate | Verify at intake | Care team can help with PA |
| NovoCare Pharmacy (Novo Nordisk direct) | $0 — no membership | $149/mo for 1.5 mg and 4 mg (4 mg offer through Aug 31, 2026, then $199); $299/mo for 9 and 25 mg | $199/mo intro × 2 mo for new patients on 0.25/0.5 mg (through June 30, 2026); $349/mo standard; $399/mo for 7.2 mg HD | n/a (Novo doesn't make Zepbound) | n/a | n/a — direct self-pay only |
| LillyDirect (Eli Lilly direct) | $0 — no membership | n/a | n/a | Vial: $299 (2.5 mg), $399 (5 mg), $449 (7.5–15 mg). KwikPen: $449/mo for 7.5–15 mg with offer; higher if refill rules missed ($499 or $699) | $149/mo starter dose; $349/mo at top dose regular price; $299/mo purchase offer for 14.5 mg and 17.2 mg when refill rules are met | n/a — direct self-pay only |
★ = WPG affiliate. Sources: Ro pricing page; Sesame Care medication pages; Amazon News GLP-1 announcement; Hims & Hers investor announcements (March 2026); GoodRx Care Direct; Walgreens Weight Management; WW Med+; PlushCare; NovoCare Wegovy Price Guide PDF; LillyDirect Zepbound Self-Pay Journey Program; FDA Foundayo approval.
What we could not verify before checkout
- Final clinical eligibility — a clinician decides at intake
- Exact insurance approval — depends on your plan and PBM
- State-by-state clinician availability — changes by month
- Pharmacy inventory at any given moment
- Whether a limited-time promotional offer is still live when you click
- Exact Hims/Hers checkout prices by dose (no public price guide like NovoCare)
- Cancellation and refund terms after medication ships (varies by provider, plan, and order status — confirm at intake)
See what your insurance covers before you assume you have to pay cash. Takes about 2 minutes.
Ro Body — best overall for FDA-approved GLP-1 care
Quick answer
What Ro actually does
- Carries the full FDA-approved menu. Wegovy pill. Wegovy pen. Zepbound pen. Zepbound KwikPen. Foundayo. Plus Ozempic and Mounjaro for clinically appropriate cases.
- Matches manufacturer cash pricing. Ro's medication prices match LillyDirect, NovoCare, and TrumpRx. You don't pay a telehealth markup on the drug itself.
- Prepay & Save. With an annual plan, Ro says you can save $50/month on the Wegovy pill, $100/month on the Wegovy pen, and up to $150/month on the highest Wegovy pen dose — plus the membership drops to as low as $74/month.
- Free GLP-1 Insurance Coverage Checker. Run it before you commit to anything. Tells you whether your specific plan is likely to cover Wegovy or Zepbound. No payment, no signup.
- Insurance concierge. Helps file prior authorization and manage the back-and-forth with your insurer.
- Ongoing clinician access. Messaging, dose-titration support, side-effect management.
Ro's government insurance limit
Ro says it cannot coordinate GLP-1 coverage for government insurance plans except FEHB (the Federal Employees Health Benefits program). If you're on Medicare, Medicaid, Tricare, or VA coverage, Ro can still serve you on a self-pay basis, but the concierge won't be working your government plan. See the Medicare GLP-1 Bridge section below for the Medicare path starting July 1, 2026.
Ro is best for
- People with commercial insurance who need help getting it to pay
- People deciding between multiple brand-name options (Wegovy vs. Zepbound vs. Foundayo)
- People who want one platform handling everything instead of stitching together a prescriber, a pharmacy, and a prior-auth appeal
The honest tradeoff
What most 'best of' pages won't tell you about Ro
Ro is not the cheapest path if you're paying cash and don't need insurance support. If you already have a prescriber, NovoCare (for Wegovy) or LillyDirect (for Zepbound and Foundayo) will give you the same medication at the same price — without the membership fee. Amazon Pharmacy also offers Wegovy and Foundayo from $149/month with no membership required. And if your priority is the lowest platform fee on a cash-pay route, GoodRx Care Direct at $39/month or Walgreens at $49/visit will beat Ro on raw cost.
But here's why Ro still ranks first: most people searching for FDA-approved GLP-1s don't just want the drug. They want help — help figuring out what their insurance covers, help filing prior auth, help choosing between five different medications, help when side effects kick in. That help is the entire reason Ro charges a membership fee. It's worth it if your real problem isn't price, it's friction.
If price is your only issue and you don't need any of that help, scroll down to When to skip telehealth and go direct. We mean it.
What Ro members say
"I was thrilled to not have to fight for my coverage."
"Nothing came close..."
"This has changed my life in so many ways."
— Ro members were paid for these testimonials per Ro's disclosure. Individual results vary and are not typical.
Ro pricing, one more time, in plain English
| Medication | Month 1 price | Ongoing price | With Prepay & Save (annual) |
|---|---|---|---|
| Wegovy pill (1.5 mg, 4 mg) | $149/mo | $149/mo | $99/mo (save $50) |
| Wegovy pill (9 mg, 25 mg) | $299/mo | $299/mo | $249/mo (save $50) |
| Wegovy pen (0.25–2.4 mg) | $199/mo intro × 2 mo | $349/mo | $249/mo (save $100) |
| Wegovy pen HD 7.2 mg | $399/mo | $399/mo | $249/mo (save $150) |
| Zepbound KwikPen (2.5 mg) | $299/mo | $299/mo | Not currently in Prepay offer |
| Zepbound KwikPen (5 mg) | $399/mo | $399/mo | Not currently in Prepay offer |
| Zepbound KwikPen (7.5–15 mg) | $449/mo | $449/mo | Not currently in Prepay offer |
| Foundayo (starter dose) | $149/mo | $199–$299/mo | Verify at intake |
| Ro platform fee | $39 (month 1) | $149/mo | As low as $74/mo on annual plan |
Source: Ro pricing page (ro.co/weight-loss/pricing), verified May 2026. Prices subject to change. Medication billed separately from platform fee. Prescription not guaranteed.
Get started with Ro — $39 the first month →Ro vs Sesame Care — which is better for FDA-approved GLP-1s?
Quick answer
| Factor | Ro | Sesame Care |
|---|---|---|
| Monthly fee | $39 first / $149 ongoing / $74 with annual | $99/mo, or $59/mo with annual |
| Choose your clinician? | No (assigned) | Yes — browse profiles and reviews |
| Insurance handling | Concierge files prior auth (commercial plans + FEHB only) | Provider can assist with PA; insurance accepted for eligible meds |
| Medication menu | Wegovy pill, Wegovy pen (incl. 7.2 mg HD), Zepbound pen, Zepbound KwikPen, Foundayo | Wegovy pill, Wegovy pen, Zepbound pen + vial + KwikPen, Foundayo, Saxenda, plus diabetes brands when clinically appropriate |
| Labs | Available; verify at intake | Quest labs included in most states; some excluded |
| Costco discount | No | Yes — 10% off services, $29 virtual visits |
| Government insurance | Self-pay only outside FEHB | Verify your plan at intake |
| Best for | Insurance + PA help, one-stop concierge | Clinician choice, transparent self-pay, Costco members |
If you're stuck between them and your plan is commercial, start with Ro's free Coverage Checker — it costs nothing and tells you whether your plan will cover the medication. If it won't, Sesame's lower annual rate ($59/month) makes it the cheaper place to land.
Sesame Care — best for medication breadth and choosing your own doctor
Quick answer
What Sesame actually does
- One of the broadest brand-name menus. Includes FDA-approved weight-loss options (Wegovy, Zepbound, Foundayo, Saxenda) plus diabetes brands (Ozempic, Mounjaro) when clinically appropriate.
- Pick your own doctor. Browse profiles, read reviews, choose. No other telehealth platform on this list lets you do that.
- Insurance accepted for eligible medications.
- Labs included through Quest in most states (excluded states listed on Sesame's site).
- Costco partnership. $29 virtual visits and 10% off Sesame services for Costco members.
- Zepbound KwikPen at Sesame: dose-based pricing — $299, $398, $499, $698 depending on dose.
Sesame is best for
- People who want to compare clinicians before committing
- People with no insurance who want transparent self-pay medication prices
- Costco members
- People who want the broadest brand-name menu in one place
The honest tradeoff
Sesame is more of a marketplace than a managed program. You drive the relationship with whichever doctor you pick. If you want a high-touch concierge experience where one team manages your whole journey, Ro is the better fit. If you'd rather control the experience yourself, Sesame is the better fit.
Browse Sesame doctors and current pricing →Best if provider choice matters more than a one-stop concierge program. Membership and medication billed separately.
Which FDA-approved GLP-1 provider is cheapest without insurance?
Quick answer
| Cash-pay option | Platform fee | Lowest medication price | Best for |
|---|---|---|---|
| NovoCare Pharmacy | $0 | Wegovy pill $149/mo (1.5 mg, 4 mg) | Already have a prescription for Wegovy |
| LillyDirect | $0 | Foundayo $149/mo (starter); Zepbound vial $299/mo (2.5 mg) | Already have a prescription for Zepbound or Foundayo |
| Amazon One Medical / Amazon Pharmacy | No One Medical membership required | Wegovy pill, Foundayo from $149/mo; injectables from $299/mo | Want transparent pricing + 50-state shipping |
| GoodRx Care Direct | $39/mo care fee | Foundayo, Wegovy pill from $149/mo | Want simplest low-fee subscription |
| Walgreens Weight Management | $49/visit, no subscription | FDA-approved GLP-1s from $149/mo | Want no subscription, pay-as-you-go |
| Sesame Care (annual) | $59/mo on annual plan | Wegovy pill from $149/mo, Zepbound from $299/mo | Want clinician choice + lower annual rate |
| Ro Body (annual) | $74/mo on annual plan | Matches manufacturer pricing + Prepay & Save | Want insurance concierge even if paying cash |
The big question: do you already have a prescriber willing to write you a GLP-1 prescription? If yes, NovoCare, LillyDirect, or Amazon will be cheapest. If no, you need a telehealth platform to get the prescription written — and the lowest platform fee that includes a clinician is GoodRx Care Direct at $39/month or Walgreens at $49 per visit.
Hims and Hers — best for mainstream brand familiarity
What changed at Hims and Hers in 2026
Hims & Hers announced in March 2026 (investor announcements March 9 and March 26, 2026) that affiliated providers can now route Zepbound and Foundayo prescriptions directly to LillyDirect Pharmacy. This means Hims and Hers readers can now access the full Wegovy menu and have Zepbound/Foundayo prescriptions sent to LillyDirect for fulfillment.
Hims / Hers is best for
- People who trust the Hims or Hers brand and want a full Wegovy menu (pill, pen, HD)
- People who want Zepbound or Foundayo routed to LillyDirect for fulfillment
- People who prefer a polished, app-first experience
Hims / Hers pricing
| Medication | Price | Notes |
|---|---|---|
| Platform fee (Hims or Hers) | $39 first month, renews at $149/mo | Not all 50 states |
| Wegovy pill (1.5/4/9/25 mg) | From $149/mo | Novo Nordisk access; dose-based |
| Wegovy injection (0.25–2.4 mg) | From $149/mo | Novo Nordisk access; 7.2 mg HD available |
| Zepbound | Prescriptions routed to LillyDirect Pharmacy | Source: Hims & Hers March 2026 investor announcement |
| Foundayo | Prescriptions routed to LillyDirect Pharmacy | Source: Hims & Hers March 2026 investor announcement |
The honest tradeoff
- Hims & Hers does not publish a complete public price guide the way NovoCare does — exact per-dose prices require going through checkout
- Not available in all 50 states; verify availability at checkout
- Self-pay focused — if your real need is insurance help, Ro is the better fit
- Polished app experience; familiar brand for readers who have used Hims or Hers for other health products
- LillyDirect prescription routing is a genuine upgrade for Zepbound and Foundayo access
Amazon One Medical, GoodRx Care Direct, Walgreens, WeightWatchers Clinic, and PlushCare — when these win
We don't run affiliate links to all of these providers. We're including them because they're real options that legitimately fit certain readers, and your search deserves the full picture — not just the providers that pay us.
Amazon One Medical / Amazon Pharmacy — best transparent-pricing retailer route
- No One Medical membership required to start GLP-1 care
- Wegovy pill and Foundayo from $149/month; injectables (Wegovy injection, Zepbound) from $299/month
- Ships to all 50 states through Amazon Pharmacy
- Transparent pricing before you commit — no paywall to see costs
- Best for readers who want a familiar retailer brand, nationwide shipping, and clear pricing without a subscription
GoodRx Care Direct — best low-fee cash-pay route
- $39/month care fee — the lowest subscription fee among GLP-1 telehealth platforms
- Wegovy pill, Foundayo from $149/month; Wegovy injection from $199/month; Zepbound from $299/month
- Not available in Alabama or Louisiana
- GoodRx Care Direct is not insurance — this is a cash-pay platform
- Best for people who want a simple, low-fee, FDA-approved-only path and don't need an insurance concierge
Walgreens Weight Management — best no-subscription option
- $49 per visit. No subscription. No membership.
- FDA-approved GLP-1s — Wegovy, Zepbound, Foundayo, Saxenda — starting at $149/month
- Zepbound KwikPen pricing is dose-based: $299, $399, $449 with manufacturer offer (higher if refill-timing rules are missed)
- Does not currently handle insurance or prior authorization — if your real problem is coverage, this isn't the right fit
- Labs required for refills
- Best for people who want a recognizable pharmacy brand and pay-as-you-go pricing
WeightWatchers Clinic (Med+) — best coaching-supported route
- Med+ starts at $25 first month with a 12-month plan, then $74/month
- Medication separate
- Clinicians prescribe FDA-approved options including Wegovy, Saxenda, Zepbound, and now Foundayo when clinically appropriate
- Insurance coordinator helps with coverage, prior authorization, and refills
- Includes the WeightWatchers behavior-change program — this is the differentiator
- Best for people who want lifestyle support alongside medication, not just a prescription
PlushCare — best traditional online doctor route
- Visit and membership pricing — verify current rates on PlushCare's site
- Lists FDA-approved weight-loss GLP-1s including Wegovy, Saxenda, and Zepbound
- Care team can help with prior authorization
- Best for people who want a primary-care-style online doctor visit, not a GLP-1-specific shopping experience
When to skip telehealth and go direct to NovoCare or LillyDirect
Quick answer
NovoCare Pharmacy — Wegovy direct from Novo Nordisk
- Wegovy injection: $199/month first 2 months for new patients on the 0.25 mg or 0.5 mg dose (offer runs through June 30, 2026), then $349/month standard for 0.25–2.4 mg, and $399/month for the 7.2 mg HD dose.
- Wegovy pill: $149/month for the 1.5 mg and 4 mg doses (4 mg intro pricing through August 31, 2026, then $199/month). $299/month for 9 mg and 25 mg doses.
- HSA/FSA eligible
- No membership fee
- You bring the prescription from any U.S.-licensed prescriber
LillyDirect — Zepbound and Foundayo direct from Eli Lilly
- Zepbound single-dose vial: $299/month (2.5 mg), $399/month (5 mg), $449/month (7.5, 10, 12.5, 15 mg)
- Zepbound KwikPen: $449/month for 7.5–15 mg doses with the manufacturer offer; if refill-timing rules are missed, higher-dose refills can rise to $499 or $699
- Foundayo: $149/month for the starter dose; up to $349/month at the top doses (regular price). A purchase offer of $299/month is available for the 14.5 mg and 17.2 mg doses when refill-timing rules are met.
- HSA/FSA eligible
- No membership fee. You bring the prescription.
TrumpRx — government-affiliated discount portal
TrumpRx is an alternate pricing channel that links to manufacturer direct-to-consumer discount programs. Wegovy injectables run $199 first 2 months to $399/month, Zepbound KwikPen up to $699/month, Wegovy pill up to $299/month, and Foundayo up to $349/month at the highest doses.
The honest tradeoff
Going direct to NovoCare or LillyDirect is unbeatable on raw cost if you already have a prescriber. You give up: dose-titration support over time, side-effect management chat, prior-auth handling, easy switching between medications, and a single platform for refills. For most readers, that scaffolding is worth a small monthly fee. But if you've been on a GLP-1 before, manufacturer-direct is often the right call.
Which online GLP-1 provider helps with prior authorization?
Quick answer
The PBM landscape, plain English
Your insurance card has a logo (Aetna, Cigna, UnitedHealthcare, Blue Cross). The pharmacy benefit manager — PBM — is the company actually deciding which GLP-1s your plan covers.
- CVS Caremark removed Zepbound from its standard formulary effective July 1, 2025, while keeping Wegovy and Saxenda as preferred options. Employer and custom formularies can differ.
- OptumRx (UnitedHealthcare) generally requires prior authorization for GLP-1 weight-loss medications. Specific criteria vary by plan.
- Cigna (Express Scripts) generally treats GLP-1s under a class prior-authorization with quantity limits.
What insurers usually want for prior authorization
- BMI ≥30, or ≥27 with a qualifying weight-related condition
- Documentation of previous weight-loss attempts (diet, exercise, prior medications)
- Sometimes step therapy — try one medication first before approving another
- Diagnosis codes for any qualifying conditions
The manufacturer savings cards
Why Ro's concierge matters here
Ro's insurance concierge runs the Coverage Checker before you pay anything, helps file the prior authorization with supporting documentation, and helps manage appeals. The catch: Ro cannot coordinate GLP-1 coverage for government insurance plans except FEHB. If you're on Medicare, Medicaid, Tricare, or VA, see the Medicare Bridge section below for your path.
If your plan flatly excludes weight-loss drugs (no GLP-1 will ever be covered for weight management), no concierge can fix that. Your real options become self-pay or an appeal under a different indication — for example, cardiovascular risk for Wegovy or obstructive sleep apnea for Zepbound when clinically appropriate.
Run Ro's free GLP-1 Coverage Checker →Free. Takes about 2 minutes. Tells you what your plan covers before you commit.
Medicare GLP-1 Bridge — $50/month starting July 1, 2026
Quick answer
What's covered through the Bridge
- Foundayo — all formulations
- Wegovy — tablets and injection
- Zepbound — KwikPen formulation only
What's NOT covered
- Zepbound single-dose vials and single-dose pens — explicitly excluded
- Ozempic and Mounjaro — continue under standard Part D for type 2 diabetes, not the Bridge
- Compounded semaglutide or tirzepatide
CMS Bridge eligibility — the actual criteria
CMS lists three eligibility paths. You must meet one of these:
- BMI ≥35, OR
- BMI ≥30 with one of the following: heart failure with preserved ejection fraction (HFpEF), uncontrolled hypertension, or chronic kidney disease (CKD) stage 3a or higher, OR
- BMI ≥27 with one of the following: prediabetes, previous myocardial infarction (heart attack), previous stroke, or symptomatic peripheral artery disease
You must also be enrolled in Medicare Part D or an MA-PD plan, and your prescriber must submit a prior authorization to the CMS central processor confirming the clinical criteria were met when GLP-1 therapy started.
The catches
- The Bridge operates outside the standard Part D benefit
- The $50 fixed cost-sharing does not count toward True Out-of-Pocket (TrOOP) accumulation or your Part D deductible
- The low-income subsidy (Extra Help) does not apply to Bridge drugs
- CMS is extending the GLP-1 Bridge through December 31, 2027
If you're currently on Zepbound vials
Source: Centers for Medicare & Medicaid Services (CMS), Medicare GLP-1 Bridge program page.
Who shouldn't use this ranking
We'd rather lose you to the right page than keep you here and waste your time.
- If you want compounded GLP-1s for the lower price — this is the wrong page. See Best GLP-1 Online Programs for an honest comparison.
- If you have type 2 diabetes and want a diabetes-first ranking — see Best GLP-1 for Diabetes.
- If you're under 18, pregnant, or planning pregnancy — this is an adult telehealth comparison and isn't the right route for you.
- If you have a personal or family history of medullary thyroid cancer or MEN2 — GLP-1s carry a boxed warning. This is a hard contraindication. Talk to your doctor first.
- If you're in a medical emergency — call 911 or your doctor. This is a comparison page, not urgent care.
Our methodology — how we ranked these providers
Quick answer
Scoring framework
| Category | Weight |
|---|---|
| FDA-approved medication menu and clarity | 25% |
| True-cost transparency (verifiable pricing, including ongoing cost after intro pricing) | 20% |
| Insurance and prior-authorization support | 20% |
| Match to specific reader segment (insurance-sensitive, cash-pay, no-subscription, etc.) | 15% |
| Practical friction (state availability, lab requirements, refill policies, cancellation terms) | 10% |
| Trust and proof signals (legitimate testimonials, disclosure, regulatory standing) | 10% |
What hurt a provider's ranking
- Compounded-first positioning (this page is FDA-approved-only)
- Pricing hidden until checkout
- No prior-authorization help for insurance-sensitive readers
- Promotional pricing without clearly stated renewal cost
- Vague or missing cancellation terms
What didn't count
- Star ratings without verifiable user reviews
- Unsourced testimonials
- “Clinical superiority” claims that aren't backed by trial data
- Affiliate commission rate
Brand identity statement
Frequently asked questions
Still not sure which path fits your situation?
If you're stuck choosing between insurance, cash-pay, manufacturer-direct, and oral vs. injection, take our free 60-second matching quiz. We'll match you to the provider best suited to your specific situation, with an estimated all-in monthly cost.
Take our free 60-second matching quiz →Sources, verification, and disclosure
Last verified: . We re-verify pricing and provider policies monthly. Manufacturer pricing pages, FDA approval announcements, and CMS Medicare Bridge details are re-checked at least monthly or whenever a regulatory update occurs.
Primary sources used to build this page:
- FDA prescribing information for Wegovy, Zepbound, Foundayo, and Saxenda (and DailyMed for current labels)
- FDA press releases on Foundayo approval (April 1, 2026) and Wegovy HD 7.2 mg approval (March 2026)
- FDA's communications on concerns with unapproved GLP-1 drugs used for weight loss
- Novo Nordisk announcement on Wegovy pill FDA approval (December 2025)
- Teva announcement on FDA approval and launch of generic Saxenda (liraglutide), August 2025
- NovoCare Wegovy Price Guide (published PDF) and NovoCare Pharmacy program pages
- LillyDirect Zepbound Self-Pay Journey Program and Foundayo program pages
- Ro Body pricing page (ro.co/weight-loss/pricing) and weight-loss landing page
- Sesame Care online weight-loss program page and medication-specific pages
- Hims & Hers investor announcements (March 9 and March 26, 2026; LillyDirect prescription-routing announcement)
- Amazon News on Amazon One Medical GLP-1 Management Program with Amazon Pharmacy fulfillment
- GoodRx Care Direct GLP-1 page
- Walgreens Weight Management page and Foundayo page
- WeightWatchers Clinic Med+ and Foundayo pages
- PlushCare GLP-1 prescription page
- CMS Medicare GLP-1 Bridge program page
- AP News reporting on CVS Caremark formulary changes (2025)
- Published clinical trial data: STEP-1 (NEJM 2021), SURMOUNT-1 (NEJM 2022), SELECT (NEJM 2023), OASIS series, ATTAIN-1
About Weight Loss Provider Guide: Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers. We may earn a commission when readers click through to certain providers. This does not affect our rankings, recommendations, or editorial independence. We are not a medical practice. Nothing on this page is medical advice. Talk to a licensed clinician before starting or stopping any medication.
By the Weight Loss Provider Guide Editorial Team.